Mitsu Chem Plast Limited Reports Impressive Q4 FY26 Performance; Net Profit Jumps 117.90%, EBITDA Up 72.98%

Mitsu Chem Plast Limited Reports Impressive Q4 FY26 Performance; Net Profit Jumps 117.90%, EBITDA Up 72.98%

Navi Mumbai (Maharashtra) [India], May 4: Mitsu Chem Plast Limited (Mitsu, The Company) (BSE:540078), one of the leading global manufacturers of blow-molded and injection-molded products and a specialist in Hospital furniture components, Infrastructure Products, Packaging Bottles, Drums, Jerry Cans, Pails, and Caps, has announced its Audited Financial Results for Q4 FY26.

Key Financial Highlights

Q4 FY26

  • Total Income of ₹ 8,679.47 Lakhs,
  • EBITDA of ₹ 1,422.74 Lakhs, YoY growth of 72.98%
  • EBITDA Margin of 16.45%, YoY growth of 736 Bps
  • Net Profit of ₹ 771.73 Lakhs, YoY growth of 117.90%
  • Net Profit Margin (%) of 8.92%, YoY growth of 501 Bps
  • EPS of ₹ 5.68, YoY growth of 117.62%

FY26

  • Total Income of ₹ 35,084.56 Lakhs, YoY growth of 5.40%
  • EBITDA of ₹ 3,466.31 Lakhs, YoY growth of 48.88%
  • EBITDA Margin of 9.90%, YoY growth of 289 Bps
  • Net Profit of ₹ 1,561.87 Lakhs, YoY growth of 115.40%
  • Net Profit Margin (%) of 4.46%, YoY growth of 228 Bps
  • EPS of ₹ 11.50, YoY growth of 113.36%

Commenting on the performance, Mr. Jagdish Dedhia, Chairman of Mitsu Chem Plast Limited said,“Q4 FY26 has been a satisfying close to what has been a year of steady and purposeful progress for Mitsu Chem Plast. We delivered meaningful improvement in profitability during the quarter, driven by disciplined execution, better operating efficiencies, and a continued focus on higher value-added products. Our Furnastra healthcare furniture vertical continues to scale well, and our export business remains on a strong growth trajectory spanning more than 17 countries.

We are also excited about our strategic entry into the Intermediate Bulk Container vertical, which we believe is a natural and well-timed extension of our packaging capabilities and will open a significant new avenue for growth. As we step into FY27, we remain committed to disciplined capital deployment, operational excellence, and delivering sustainable long-term value for all our stakeholders.”

Q4 FY26 Key Operational Highlights

Capacity Expansion & Global Business Strengthening • A planned addition of ~900 MT per annum, taking total installed capacity to ~29,900+ MT per annum, with commencement of operations at the new Boisar facility (Unit 4) in January 2026. 
• Entered into a Global Supplier Agreement with Arjohuntleigh Polska (Poland), marking onboarding as a global supplier to a leading medical equipment group. 
• Strengthens presence in the healthcare vertical, expands export opportunities, and enhances global brand visibility while supporting long-term growth.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Tags: PNN